Download PDF
Nuklearmedizin 2017; 56(03): N19-N21
DOI: 10.3413/Nukmed-0863-16-11
Case report
Schattauer GmbH

Repeated peptide receptor radiotherapy in multiple recurrences of a metastasized neuroendocrine tumor

Claudia Brogsitter
1   Nuclear Medicine Department, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
Klaus Zöphel
1   Nuclear Medicine Department, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
Gunnar Folprecht
2   Medical Department I, University Cancer Center, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
Grame Eisenhofer
3   Medical Department III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
Jörg Kotzerke
1   Nuclear Medicine Department, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
› Author Affiliations
Further Information

Publication History

received: 22 November 2016

accepted in revised form: 03 February 2017

Publication Date:
02 January 2018 (online)

Also available at
   Permissions and Reprints

 

 

  • References

  • 1 Bodei L, Mueller-Brand J, Baum RP. et al. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2013; 40: 800-816.
    CrossrefSearch in Google Scholar
  • 2 Kong G, Callahan J, Hofman MS. et al. High clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2017; 44 (03) 476-489.
    CrossrefSearch in Google Scholar
  • 3 Pavel M, Baudin E, Couvelard A. et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2012; 95: 157-176.
    CrossrefSearch in Google Scholar
  • 4 Rolleman EJ, Krenning EP, Bernard BF. et al. Longterm toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats. Eur J Nucl Med Mol Imaging 2007; 34: 219-227.
    CrossrefSearch in Google Scholar
  • 5 Sadowski SM, Neychev V, Millo C. et al. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. J Clin Oncol 2016; 34: 588-596.
    CrossrefPubMedSearch in Google Scholar